PAION Deutschland GmbH

🇩🇪Germany
Ownership
Subsidiary
Employees
-
Market Cap
-
Website
http://www.paion.com
Clinical Trials
Related News

Desmoteplase in Acute Ischemic Stroke (DIAS)

Phase 2
Completed
Conditions
Stroke
Interventions
Drug: Placebo
Drug: Desmoteplase
First Posted Date
2008-03-19
Last Posted Date
2008-03-19
Lead Sponsor
PAION Deutschland GmbH
Target Recruit Count
104
Registration Number
NCT00638781
Locations
🇩🇪

Prof. Dr. Werner Hacke, Heidelberg, Germany

Dose Escalation of Desmoteplase in Acute Ischemic Stroke (DEDAS)

Phase 1
Completed
Conditions
Stroke
Interventions
Drug: Desmoteplase
Drug: Placebo
First Posted Date
2008-03-19
Last Posted Date
2008-03-19
Lead Sponsor
PAION Deutschland GmbH
Target Recruit Count
38
Registration Number
NCT00638248

Tolerability of Enecadin (INN) in Acute Ischemic Stroke Trial - TEST

Phase 2
Terminated
Conditions
Stroke
Interventions
Drug: Placebo
Drug: Enecadin
First Posted Date
2006-05-31
Last Posted Date
2008-05-22
Lead Sponsor
PAION Deutschland GmbH
Target Recruit Count
24
Registration Number
NCT00331721
Locations
🇦🇹

Investigational Site 1, Linz, Austria

🇦🇹

Investigational Site 2, Linz, Austria

🇩🇪

Investigational Site, Wiesbaden, Germany

and more 1 locations
© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy